FDA skeptical of benefits from experimental ALS drug

Canada News News

FDA skeptical of benefits from experimental ALS drug
Canada Latest News,Canada Headlines
  • 📰 wsfa12news
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 59%

The drug from Amylyx Pharmaceuticals has become a rallying cause for patients with the deadly neurodegenerative disease ALS, their families and members of Congress who’ve joined in pushing the FDA to greenlight the drug.

WASHINGTON — Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, after months of lobbying by patient advocates urging approval.

The meeting is being closely watched as an indicator of the FDA’s approach to experimental drugs with imperfect data and its ability to withstand outside pressure. Amylyx’s drug is a combination of two older drugs: a prescription medication for liver disorders and a dietary supplement associated with traditional Chinese medicine. Amylyx has patented the combination and says the chemicals help protect cells from early death.

After further discussions, Amylyx decided to submit its pill for approval based on survival data gathered after its initial study. The company said that showed patients who took the drug lived about six months longer than those taking a dummy pill. Currently, there are only two FDA-approved drugs for ALS, the more effective of which extends life by several months.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

wsfa12news /  🏆 338. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA: Nationwide recall of Milk of Magnesia, other medicines due to possible contaminationPlastikon Healthcare, based in Kansas, is voluntarily recalling a select number of products sold nationally due to possible bacteria contamination.
Read more »

Nationwide recall of Milk of Magnesia due to possible bacterial contamination: FDANationwide recall of Milk of Magnesia due to possible bacterial contamination: FDAThe popular over-the-counter product for heartburn and constipation could cause intestinal distress instead if it's from the contaminated lots.
Read more »

Nationwide recall of Milk of Magnesia due to possible bacterial contamination: FDANationwide recall of Milk of Magnesia due to possible bacterial contamination: FDAThe popular over-the-counter product for heartburn and constipation could cause intestinal distress instead if it's from the contaminated lots.
Read more »

Nationwide recall of Milk of Magnesia due to possible bacterial contamination: FDANationwide recall of Milk of Magnesia due to possible bacterial contamination: FDAThe popular over-the-counter product for heartburn and constipation could cause intestinal distress instead if it's from the contaminated lots.
Read more »

Nationwide recall of Milk of Magnesia due to possible bacterial contamination: FDANationwide recall of Milk of Magnesia due to possible bacterial contamination: FDAThe popular over-the-counter product for heartburn and constipation could cause intestinal distress instead if it's from the contaminated lots.
Read more »

FDA expected to OK additional Covid-19 booster shots for adults over 50 next weekFDA expected to OK additional Covid-19 booster shots for adults over 50 next weekTwo sources familiar with the government's plans said the US Food and Drug Administration is planning authorize a fourth dose of the Pfizer and Moderna mRNA vaccines for adults over age 50 next week.
Read more »



Render Time: 2025-03-06 14:43:37